Wi-fi Surgical Digicam Maker Lazurite® To Current At LSI Rising MedTech Summit And MedInvest Convention
Lazurite® President Leah Brownlee will current at this yr’s Life Science Intelligence’s Rising MedTech Summit, March 21-23 in Dana Level, California, and Lazurite CEO and cofounder Eugene Malinskiy will current on the MedInvest Convention, March 28-29 in Palo Alto, California. The corporate is in search of traders for a Collection B spherical of funding.
Lazurite is the developer of ArthroFree®, the primary wi-fi digicam system cleared by the FDA for arthroscopy and basic endoscopy. By eliminating typical digicam and energy cables that tether the surgeon to the surgical tower, the ArthroFree System reduces litter within the sterile discipline and enhances surgeon movement and dexterity. It additionally eliminates camera-cable-related affected person burns and OR fires. ArthroFree’s efficiencies, together with quicker setup and takedown instances, supply projected cost-per-case financial savings as much as 20%.
“The ArthroFree System has now been utilized in practically 100 instances at services across the nation, together with NYU Langone, Hospital for Particular Surgical procedure, Rush Medical Heart in Chicago, and College Hospitals in Cleveland,” Brownlee stated. “Greater than 70 doctor traders function inner champions for ArthroFree in additional than 60 well being methods that we’ve engaged with for product acquisition.”
On the LSI Summit, which connects early-stage medtech corporations with traders, Brownlee will element ArthroFree’s benefits in contrast with each typical surgical digicam methods and rising disposable methods and supply an replace on advertising efforts within the yr since FDA clearance on March 23rd at 11:10 a.m.
She additionally will seem on the panel “What IP Points Actually Matter? Views from All Sides of Diligence” on March 21st at 12:45 p.m.
The MedInvest Convention is a number one convention collection in biotech and medtech. The primary goal of the convention is to assist early and mid-stage medtech corporations and traders to accomplice with each other.
